UK markets open in 5 hours 51 minutes
NIKKEI 225
38,242.07 +39.70 (+0.10%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.32 +0.33 (+0.42%) GOLD FUTURES
2,316.20 -6.10 (-0.26%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,178.26 -897.98 (-1.79%)
Revelation Biosciences, Inc. (REVB)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.64M |
| Enterprise value | 9.87M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.55 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.14 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.12 |
| 52-week change 3 | -93.22% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 39.0000 |
| 52-week low 3 | 1.7800 |
| 50-day moving average 3 | 2.5774 |
| 200-day moving average 3 | 13.5371 |
Share statistics
| Avg vol (3-month) 3 | 195.39k |
| Avg vol (10-day) 3 | 30.58k |
| Shares outstanding 5 | 1.63M |
| Implied shares outstanding 6 | 1.65M |
| Float 8 | 1.63M |
| % held by insiders 1 | 0.32% |
| % held by institutions 1 | 1.96% |
| Shares short (15 Apr 2024) 4 | 18.54k |
| Short ratio (15 Apr 2024) 4 | 0.28 |
| Short % of float (15 Apr 2024) 4 | 1.14% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.14% |
| Shares short (prior month 15 Mar 2024) 4 | 32.78k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 25 Jan 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -61.08% |
| Return on equity (ttm) | -3.12% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -8.63M |
| Net income avi to common (ttm) | -120.25k |
| Diluted EPS (ttm) | -0.5300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 11.99M |
| Total cash per share (mrq) | 7.34 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.18 |
| Book value per share (mrq) | 25.13 |
Cash flow statement
| Operating cash flow (ttm) | -7.29M |
| Levered free cash flow (ttm) | -4.11M |
© 2024 Yahoo. All rights reserved.